Report: More healthcare deals, but less money exchanged

Editorial Staff | | Health Exec | Precision Medicine

While the frequency of healthcare deals held steady through the final three months of 2012, companies engaged in fewer high-ticket megadeals, according to Healthcare M&A Watch, a report series that examines trends in U.S. mergers and acquisitions.

During the last quarter of 2012, companies entered into 358 deals compared to 350 in the third quarter, the results found. While the rising number of deals looked promising on the surface, they represented $22 billion, or a 40 percent drop, from the $36.9 billion in third-quarter deals.

Overall, the fourth quarter only saw four deals that exceeded $1 billion, including UnitedHealth Group’s $4.9 billion transaction for a majority stake in Brazilian insurer and provider Amil Participacoes, Baxter International’s $4 billion bid on Swedish dialysis equipment manufacturer Gambro, McKesson’s $1.8 acquisition of PSS World Medical and HCP’s $1.7 billion deal for 133 senior housing communities.

In other findings, the report revealed that the largest single deal recorded in the quarter was within the payer segment; financial investor involvement declined in terms of volume as well as value from the previous quarter; and international companies were involved in 64 U.S. healthcare deals during the fourth quarter.

 

Editorial Staff

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Cardiovascular Business
Why electrophysiologists needed a champion in Washington

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.